Recently, Jingrui Medical Technology (Shenzhen) Co., Ltd. announced the completion of the pre-A round of financing of tens of millions. This round of financing was led by Taipu Life Science Investment. Luo Xu, chairman and CEO of the company, said that the funds raised will mainly be used for core technology research and development, production capacity construction and verification of key clinical application scenarios, accelerate magnetic resonance compatible monitoring equipment and a series of hard technology products based on autonomous anti-magnetic technology platforms, achieve large-scale mass production and clinical promotion, and promote the localization process of high-end medical equipment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.